NCT05074849

Brief Summary

Novel approaches to promote adherence to diabetic footwear and prevent high incidence of diabetes foot ulcers are urgently needed. Investigators propose to translate an innovative and practical technology to supplement clinical and risk evaluation for patients with diabetes through wearable insoles and smart watch, along with foot self-care education, to improve adherence to prescribed footwear and reduce incidence of foot ulcers in those with diabetes and at risk for foot ulcers.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Oct 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 12, 2021

Completed
5 years until next milestone

Study Start

First participant enrolled

October 20, 2026

Expected
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

1 month

First QC Date

August 13, 2021

Last Update Submit

April 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • A Change in Adherence to prescribed footwear is being assessed

    Daily adherence will be track by Sensor Data and Self-Report Questionnaire. The real-time alert component of the smart insoles will be measured by the tagging of patients' diabetes shoes by Orthimeter (Germany). The system has 1-year battery life and enables continuous measuring adherence to footwear by measuring temperature. Participants will be required to record number of days adhered to footwear or alerts.

    2 months, 4 months and 6 months

Secondary Outcomes (3)

  • A change in Response Rate to Alert and Unreported Alert Duration is being assessed

    2 months, 4 months and 6 months

  • A change in Foot Self-Care knowledge is being assessed

    Baseline and 6 months

  • A change in Perception of Benefits is being assessed

    2 months, 4 months and 6 months.

Other Outcomes (4)

  • A change in Adherence to device wear is being assessed

    2 months, 4 months and 6 months

  • A change in Foot Ulcers is being assessed

    Baseline and 6 months

  • A change in Off loading is being assessed

    2 months, 4 months, and 6 months

  • +1 more other outcomes

Study Arms (3)

Smart insoles + Education

EXPERIMENTAL

Participants in this group will receive a 90-minute group session education on foot self-care strategies (daily foot hygiene and cleanliness, foot protection, use of insoles and smart watch)

Behavioral: A 90-minute self-care education + bi-weekly 30-minute one-on-one follow-up phone discussion

Smart Insoles

NO INTERVENTION

Participants in this group will not receive a 90-minute group session education on foot self-care, but will receive foot care supplies, insoles and smart watch

Usual Care

NO INTERVENTION

Participants will not receive foot self-care education or the use of insoles and smart watch.

Interventions

A 90-minute group session to educate patients on foot self-care strategies (daily foot hygiene and cleanliness, foot protection, use of insoles and smart watch). Follow-up Care: A biweekly 30-minute one-on-one follow-up phone discussion (i.e., daily foot hygiene and cleanliness, foot protection, use of insoles and smart watch, addressing feedback and questions regarding the intervention and prevention of foot-related complications).

Smart insoles + Education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women 18 years old or older,
  • Diagnosis of Diabetes Mellitus,
  • Ambulatory, Uses prescribed diabetes footwear.
  • Those willing and able to attend follow up visits such as long distance (i.e. greater than 30 miles to recruitment sites).
  • Those able to read or follow directions.

You may not qualify if:

  • Active Charcot Arthropathy or major foot deformity,
  • Cardiopulmonary disease (e.g. recent MI, Stroke),
  • Gangrene, active infection. Montreal Cognitive Assessment (MOCA\<20).
  • Wide spread malignancy or systemically immunocompromising disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Texas Woman's University

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Diabetes Complications

Condition Hierarchy (Ancestors)

Diabetes MellitusEndocrine System Diseases

Study Officials

  • Ngozi Mbue

    Texas Woman's University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ngozi Mbue, PhD

CONTACT

Bijan Najafi, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2021

First Posted

October 12, 2021

Study Start (Estimated)

October 20, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations